Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $9.3800 (-3.89%) ($9.3800 - $9.3800) on Mon. Mar. 21, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.97% (three month average) | RSI | 42 | Latest Price | $9.3800(-3.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.1% a day on average for past five trading days. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(50%) IBB(47%) ARKG(46%) ARKK(46%) IWO(42%) | Factors Impacting ATRA price | ATRA will decline at least -2.485% in a week (0% probabilities). VIXM(-41%) VXX(-29%) UNG(-17%) USO(-9%) UUP(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.485% (StdDev 4.97%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $10.08 | 5 Day Moving Average | $9.28(1.08%) | 10 Day Moving Average | $9.15(2.51%) | 20 Day Moving Average | $10.08(-6.94%) | To recent high | -45.8% | To recent low | 11.1% | Market Cap | $697m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |